This blog is related to the various litigations related to patents w.r.t pharma industry.
Wednesday, September 9, 2009
ChemGenex Submits New Drug Application for OMAPRO (Omacetaxine Mepesuccinate) to U.S. FDA
ChemGenex Pharmaceuticals Limited announced today the completion of its New Drug Application (NDA) submission to the U.S. FDA for OMAPRO™ (omacetaxine mepesuccinate).
No comments:
Post a Comment